F2G Announces $100 Million Financing to Advance Late-Stage Development and Commercialization of Novel Antifungal Drug Candidate Olorofim in the US

7 days ago

Financing is being led by new investor AMR Action Fund with strong participation from new investor ICG Life Sciences and existing investors

Ticker	Sentiment	Impact
MANU	Neutral	4 %